Pain management is a huge market in the medical world, as you’re no doubt aware — and buckets of money are pouring down on the many, many little biotech stocks who are trying to develop new pain medications, or to tweak existing medications to make them safer or less likely to be abused. So it’s […]
Articles
- Most Relevant
- Most Recent
I know I should stop rising to the bait of these Louis Navellier teasers … but I can’t help myself. Every month or two he throws out a new teaser along the lines of this one — some teased pick or another that is going to double “with or without you” … he’s not alone […]
Keith Fitz-Gerald and the folks at the Money Map Report are pitching something they call “Super Dividends” — payments that dwarf the typical dividend and that they say are even distinct from “special dividends.” But not content to promise big returns ($16,559 as soon as June 28, they say), they also claim that they can […]
Today we’ve got another pitch from Jason Stutman to decipher… and it’s actually fairly similar to a teaser ad he was circulating a year or two ago, though the company being hinted at this time is different. The ad is for The Cutting Edge, which will run you $1,499/yr. As with his teaser pitch last […]
The Foolies are back in our inboxes — or in mine, at least, and I can’t imagine they’re not plying their promises to the rest of you as well. This time, they’re trying to sell subscriptions to their flagship Stock Advisor newsletter, along with their annual special report on stocks for next year. We’ve looked […]
Many of the readers out there in the great Gumshoe Universe love Roger Conrad — or at least, they love his steadfast attachment to high-dividend stocks that comes through in pretty much all of his newsletters whether they focus on sexier/riskier high yields (Big Yield Hunting), boring “essential services” stuff (Utility Forecaster), Canadian or Australian […]
When I saw the recent ads for Technology Profits Confidential, edited by Patrick Cox, I almost passed them by — after all, the language and hype is quite similar to the several ads of his (for the more expensive Breakthrough Technology Report) that I wrote about in recent years, most of which touted stem cell […]
Premium-priced newsletter that aims to ride the boom in defense spending by investing in smaller “defense technology” firms and contractors. Seems to have taken the place of Agora’s previous Military-Tech Alert.
Kent Moors WWlllAnyone know what stock Moors is hawking concerning the little defense contractor who is making the $25000 Mach 7 bullet?
This article originally ran on May 24, 2016, when we were in the midst of a run on virtual reality teaser pitches that had lasted for months. Apparently the ad is running again and this older article has been difficult for readers to track down, because we’re getting lots and lots of questions about it […]
We have a very specific prediction here from Bryan Tycango, who is pitching this idea that he says could triple your money before the end of the year, so I’m stepping back from overthinking my own portfolio and the crazy gyrations of earnings season to dig into this idea. The ad is for his Strategic […]
This week I’m seeing a new wave of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the last version with the “by March 19, 2019” deadline even suggested that Yellen was still President of the […]
This particular ad from Ian Cooper has been running for six weeks or so, at least that I’ve seen, so it’s not exactly “red hot” and brand new, but I’m still getting questions about it and the ad is still being circulated… and the stock being teased is down about 20% since I first saw […]
That’s the intriguing subject line of a forwarded email a reader sent in, advertising the Untapped Wealth Newsletter that can come your way for $99 a year. It’s a nanotechnology and defense teaser, which is where that idea comes from — they’re building, or at least envisioning, little drones that are the size of bumblebees. […]
Christian DeHaemer is pushing a newsletter called Technology & Opportunity with the idea that you can “Ride the Robot Revolution” and make massive gains, just like getting in early on the computer revolution by buying Apple, Microsoft or Dell 30 years ago. And I think it’s a new letter, though I’m not certain — it’s […]
Today for our Friday pleasure I thought I’d look into another really tiny and illiquid stock — partly because lots of folks have forwarded questions about it to me, and partly because it’s hard to write about $20 million market cap companies without driving the shares crazy when I mention them on the free site. […]
OK, so I was called away before we got through the rest of Mark Skousen’s ideas for profiting from the election (which he is convinced will bring a victory for Romney and stock market ebullience) — so let’s jump right in and finish sniffing out those picks, shall we? The first three were energy and […]
Today for our Friday pleasure I thought I’d look into another really tiny and illiquid stock — partly because lots of folks have forwarded questions about it to me, and partly because it’s hard to write about $20 million market cap companies without driving the shares crazy when I mention them on the free site. […]
As I struggle out from below the mountain of incoming email teaser ads and get Stock Gumshoe back up to speed after a week of moving and unpacking here at Gumshoe HQ, there’s one thing I can do easily and quickly: share an older article. This one appeared in the Friday File for the Irregulars […]
“This is the only company in the online higher education industry that’s creating a win-win for everyone. Which means it’s the only one with long-term staying power. The sad truth is, most online colleges exist for one simple purpose. To suck away federal loan dollars from Uncle Sam. These “diploma mills” don’t even care whether […]
There’s no more cyclical stock than a semiconductor stock, and we’re seeing the whipsaw slash through that market now as trade sentiment weakens and pundits begin to see some weakness in the economy, particularly in the employment numbers, and the Federal Reserve fuels that uncertainty by essentially promising a rate cut in their attempt to […]
I’ll let you know up front that this is not a particularly “secret” stock reveal today — yes, Frank Curzio is hinting at a stock to promote his entry-level newsletter (Curzio Research Opportunities, currently $49), but you could find this stock on your own. Anyone could, that’s the nature of a unique product. But I’ve […]
Here’s your assigned reading for the week: Go check out Stop the financial pornography! from Nick Maggiulli. A good reminder of how manipulated we all can be by attention-getting investment and economic news that doesn’t really have any relevance. Don’t worry, it’s short. So… what’s up this week? Leading the news for me, outside of […]
Doc Gumshoe is not in the habit of contradicting the conclusions, backed by research, that are stated in papers published by the Journal of the American Medical Association, commonly referred to as JAMA. JAMA is, after all, one of a handful of the most prestigious medical journals on the planet, along with the New […]
I’ve got a new buy to go into in some detail today, but first let’s go through some meaningful earnings reports that shook up the Real Money Portfolio this week and sent some questions my way… The Trade Desk (TTD) beat the analyst expectations for both revenue and earnings this quarter, but not in a […]
Here is partially what he says. Any idea of what stock he is talking about? Is it one that he has pumped in earlier announcements? Dear Joseph, I wanted to reach out while there’s still time. Tomorrow I will be issuing my biggest trade alert of the year (on a $5 stock) for members of […]
This ad has been around for more than a year, and I haven’t written about it… partly because the Thinkolator doesn’t have a 100% certain match (we only get a teaser solution wrong about once a year, and I want to keep that 99%+ accuracy rate). But it is an interesting one, and I started […]
Happy weekend, campers! Here’s a good quick read for you to start the weekend from Vitaliy Katsenelson, who is a smarter guy than me. It’s called Want to Be a Better Investor? Stop Staring at Your Portfolio… and it got me thinking a little bit. Here’s a little excerpt: “You spend hundreds of hours on […]
We have a very specific prediction here from Bryan Tycango, who is pitching this idea that he says could triple your money before the end of the year, so I’m stepping back from overthinking my own portfolio and the crazy gyrations of earnings season to dig into this idea. The ad is for his Strategic […]
I got stuck in a writing quagmire today, so no new teaser solution for you — but we’ve got one from February that’s still relevant that we can share. It first appeared in a Friday File for our Irregulars on February 22, and I’ve continued to get questions about it over the past couple months. […]
I’ve been meaning to check in on one of the few mutual funds that I’ve written in detail about for you, so in the absence of any other big portfolio moves we’ll take a minute for that today. DoubleLine Shiller Enhanced CAPE (DSEEX) is a “better mousetrap” kind of fund, which should make us start […]
Frank Curzio’s latest ad for his Curzio Research Advisory newsletter ($79/yr) starts out with a pretty big promise… “There’s a one-in-three chance someone you know could be saved by this new device. “That’s because one in three Americans will die due to cardiovascular disease – the No.1 killer not only in America, but worldwide.” And […]
It seems we’ve officially entered a period of another “Fed Put” — Fed Chair Jerome Powell’s statements yesterday were widely interpreted to mean that there will be no interest rate hikes this year, or maybe ever again, and that the Fed will stop its “quantitative tightening” in six months or so, leaving a huge and […]
This pitch about “Federal Rent Checks” has been circulating for quite a while, and it’s still being mailed out with a July 2018 date under the signature (I got a few questions about it just this week), so I decided to take a second look. And what do you know, there has been a LOT […]
Nick Hodge is peddling subscriptions to his Early Advantage (currently $1,299/year, 30-day refund period promised) using the pitch that one tiny company has the patents on a key thin film sensor technology that will become the “barcode of the future” and “revolutionize Amazon’s supply chain.” So what is it? Let’s check out the details… Hodge […]
I continue to get lots of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the latest “by March 19, 2019” ad even suggests that Yellen is still President of the Federal Reserve, and the date […]
I don’t want to give you too much to read, since probably the most interesting reading this weekend will be Warren Buffett’s annual letter to shareholders (which should be posted here as part of Berkshire’s Annual Report, around 8am EST tomorrow), but I do have a quick teaser answer to share with you… and a […]
We get “rebate” and “refund” and “enrollment” check teasers all the time, it’s a popular way to give investors, especially inexperienced investors, the illusion that there’s some free way to get money that they don’t know about (which many people always suspect, anyway)… the story typically is that all you have to do is sign […]
The latest ad pitch from the Stansberry folks, a marketing letter/presentation that’s urging you to subscribe to Stansberry Innovations Report ($49/yr at the moment), tells us that… “This Tiny Firm Could Tip the Scales in… The Battle to Save the Internet” So you can leave your subtlety by the back door today. What is this […]
any one know what this [ new ? ] crypto is ? Manward newsletter or something like it ? Says it 100% american not 78% owned like BTC or ETH